Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Belgium, France, Netherlands, Switzerland
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.11 - Research And Experimental Development On Biotechnology

300 jobs
Number of planned job losses
Job loss
Announcement Date
8 January 2025
Employment effect (start)
1 February 2025
Foreseen end date

Description

Galapagos, a Belgian multinational biotech company has announced that it will cut 300 jobs worldwide.

The restructuring measures will affect employees in France, Switzerland, the Netherlands and Belgium. In total 300 employees will potentially face dismissal, approximately 200 of which in Belgium GALAPAGOS-2025-BE . The source also reports that the unit in France is expected to be closed. As required by law, the information and consultation phase between the company management and trade unions has been initiated.

The restructuring will divide the company into different sub-entities. The new company next to Galapagos is provisionally called SpinCo. All Galapagos shareholders will receive SpinCo shares according to how many Galapagos shares they hold. Additionally, some activities will be sold off to other companies, leading to dismissals as well.

Founded in 1999, Galapagos operates in the US, the Netherlands, France, Switzerland, and the UK. Galapagos is headquartered in Mechelen, Belgium. The Galapagos group currently has 1,489 employees.


Sources

Citation

Eurofound (2025), Galapagos , Internal restructuring in World, factsheet number 202249, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202249.